SUPT16H

Chr 14

SPT16 homolog, facilitates chromatin remodeling subunit

Also known as: CDC68, FACTP140, NEDDFAC, SPT16, SPT16/CDC68

Transcription of protein-coding genes can be reconstituted on naked DNA with only the general transcription factors and RNA polymerase II. However, this minimal system cannot transcribe DNA packaged into chromatin, indicating that accessory factors may facilitate access to DNA. One such factor, FACT (facilitates chromatin transcription), interacts specifically with histones H2A/H2B to effect nucleosome disassembly and transcription elongation. FACT is composed of an 80 kDa subunit and a 140 kDa subunit; this gene encodes the 140 kDa subunit. [provided by RefSeq, Feb 2009]

ResearchGenerating clinical summary…
LOFmechanismLOEUF 0.12
Clinical SummarySUPT16H
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
11 unique Pathogenic / Likely Pathogenic· 147 VUS of 222 total submissions
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.12LOEUF
pLI 1.000
Z-score 7.10
OE 0.05 (0.020.12)
Highly constrained

Among the most LoF-intolerant genes (~top 3%)

Missense Constraint?
5.10Z-score
OE missense 0.40 (0.360.45)
229 obs / 572.4 exp
Constrained

Extremely missense-constrained (top ~0.01%)

Observed / Expected Ratios?
LoF OE?0.05 (0.020.12)
00.351.4
Missense OE?0.40 (0.360.45)
00.61.4
Synonymous OE?0.97
01.21.6
LoF obs/exp: 3 / 64.6Missense obs/exp: 229 / 572.4Syn Z: 0.29
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedSUPT16H-related neurodevelopmental disorderOTHERAD

This gene — mechanism propensity

DN
0.3196th %ile
GOF
0.3491th %ile
LOF
0.70top 10%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · 27% of P/LP variants are LoF · LOEUF 0.12

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

222 submitted variants in ClinVar

Classification Summary

Pathogenic7
Likely Pathogenic4
VUS147
Likely Benign17
Benign8
7
Pathogenic
4
Likely Pathogenic
147
VUS
17
Likely Benign
8
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
1
4
2
0
7
Likely Pathogenic
2
2
0
0
4
VUS
17
124
5
1
147
Likely Benign
0
4
3
10
17
Benign
0
1
2
5
8
Total201351216183

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

34 pathogenic / likely-pathogenic (of 50) ClinVar copy-number / structural variants overlap SUPT16H — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

SUPT16H · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →